|
Volumn 32 Suppl 2, Issue , 2011, Pages
|
Lecture: profile of risks and benefits of new antiepileptic drugs in brain tumor-related epilepsy.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICONVULSIVE AGENT;
ANTINEOPLASTIC AGENT;
ARTICLE;
BRAIN TUMOR;
CLASSIFICATION;
DRUG INTERACTION;
EPILEPSY;
HUMAN;
MULTIMODALITY CANCER THERAPY;
PATIENT CARE PLANNING;
QUALITY OF LIFE;
RISK ASSESSMENT;
SEIZURE;
ANTICONVULSANTS;
ANTINEOPLASTIC AGENTS;
BRAIN NEOPLASMS;
COMBINED MODALITY THERAPY;
DRUG INTERACTIONS;
EPILEPSY;
HUMANS;
PATIENT CARE PLANNING;
QUALITY OF LIFE;
RISK ASSESSMENT;
SEIZURES;
|
EID: 85027937176
PISSN: None
EISSN: 15903478
Source Type: Journal
DOI: 10.1007/s10072-011-0801-3 Document Type: Article |
Times cited : (8)
|
References (0)
|